Topline Capital Management, LLC

Holdings History for Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Symbol: CTKB on Nasdaq
Investment type: Equity / Common Stock - $0.001 par value
Latest Disclosed Shares Owned: 6,780,847 shares
Security Ownership %: 5.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Topline Capital Management, LLC ownership in Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB)

17 Nov 2025 - Topline Capital Management, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,780,847 shares of Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB). This represents 5.3% ownership of the company. This is the first filing by Topline Capital Management, LLC disclosing ownership of Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Topline Capital Management, LLC	5.3%		$28,140,515	6,780,847			$4.15	13G	25 Sep 2025	17 Nov 2025, 11:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	4.1%	+1%	$24,096,652	6,944,280	+1,713,020	+33%	$3.47	Q3 2025
30 Jun 2025	3%	+2.2%	$17,786,284	5,231,260	+3,760,485	+256%	$3.40	Q2 2025
31 Mar 2025	1.4%	+1.1%	$5,897,808	1,470,775	+1,234,179	+500%	$4.01	Q1 2025
31 Dec 2024	0.29%	0%	$1,535,508	236,596	0		$6.49	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.